Monopar Therapeutics
MNPRNasdaqCIK 1645469HealthcareFiscal year ends Dec 31
Reports and events: 178 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1213:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-027165 |
| 2026-08-1213:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-027164 |
| 2026-07-2212:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-024041 |
| 2026-06-3012:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-022086 |
| 2026-06-2620:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-021832 |
| 2026-06-2312:00 ET | 8-K | 5.07 Shareholder vote results | 0001437749-26-021350 |
| 2026-05-2920:56 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-018896 |
| 2026-05-1921:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-017821 |
| 2026-05-1418:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-016982 |
| 2026-05-1418:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-016981 |
| 2026-04-3020:01 ET | DEF 14A | Proxy statementPeriod 2026-06-22 | 0001437749-26-014183 |
| 2026-04-2010:22 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-012751 |
| 2026-04-0116:24 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001437749-26-010841 |
| 2026-03-2717:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-010030 |
| 2026-03-2717:00 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-010025 |
| 2026-03-0213:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-006229 |
| 2026-01-3019:32 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001437749-26-002528 |
| 2025-11-1313:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034618 |
| 2025-11-1313:00 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-034617 |
| 2025-11-1013:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-033948 |
| 2025-09-2400:59 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001437749-25-029839 |
| 2025-09-2421:06 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-029819 |
| 2025-09-1511:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-029005 |
| 2025-08-1212:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-026043 |
| 2025-08-1212:00 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-026042 |
| 2025-06-2322:00 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-020959 |
| 2025-05-1312:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-016263 |
| 2025-05-1312:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-016262 |
| 2025-05-0710:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-014880 |
| 2025-04-3019:34 ET | DEF 14A | Proxy statementPeriod 2025-06-17 | 0001437749-25-013824 |
| 2025-03-3112:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-009982 |
| 2025-03-3112:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-009979 |
| 2025-03-0322:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-005951 |
| 2025-02-2422:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-004910 |
| 2025-02-0722:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001437749-25-003178 |
| 2024-12-2321:06 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-24-038286 |
| 2024-12-1722:01 ET | SC 13D/A | Ownership report, active investor, amended | 0001437749-24-037745 |
| 2024-12-0613:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-036825 |
| 2024-11-0813:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-034049 |
| 2024-11-0813:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-034048 |
| 2024-10-3020:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-032612 |
| 2024-10-2411:00 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-031957 |
| 2024-10-2212:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-031684 |
| 2024-10-1512:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-031184 |
| 2024-10-0712:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-030764 |
| 2024-09-1212:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-029012 |
| 2024-08-2720:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-027846 |
| 2024-08-2112:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-027432 |
| 2024-08-1412:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-026563 |
| 2024-08-0912:02 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-025651 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.